Ideal Body Weight (IBW) Calculator
Estimates ideal body weight using the Devine formula — the standard reference for weight-based drug dosing, mechanical ventilation tidal volume settings, and nutritional assessment.
Calculate Ideal Body Weight
Enter the patient’s sex and height to estimate ideal body weight using the Devine formula. Optionally, enter actual body weight to calculate adjusted body weight (ABW) and percentage of IBW — useful for drug dosing in obese patients.
The Devine formula estimates ideal body weight based on height and sex only. It does not account for body composition, frame size, or ethnicity. Results should be interpreted alongside clinical context. For patients shorter than 152 cm (5 ft), the formula may yield values that are less reliable — consider clinical judgement.
Understanding Ideal Body Weight
Ideal body weight (IBW) is a theoretical weight associated with the lowest mortality for a given height and sex. It was originally derived from actuarial life-insurance data in the 1960s and later simplified into the widely used Devine formula in 1974. Despite its simplicity, IBW remains the most commonly referenced weight metric in drug dosing guidelines and ventilator management protocols.
IBW is not a target weight or a measure of health — it is a pharmacological and physiological reference point. Many medications distribute primarily into lean tissue rather than adipose tissue, making IBW (rather than actual weight) the appropriate dosing scalar. Similarly, lung volume correlates more closely with height than with total body mass, making IBW the standard for calculating tidal volumes in lung-protective ventilation.
Devine Formula (1974)
Males:
IBW (kg) = 50 + 2.3 × (height in inches − 60)
Females:
IBW (kg) = 45.5 + 2.3 × (height in inches − 60)
Height must be ≥ 60 inches (152.4 cm / 5 ft). For shorter patients, the formula yields impractical values.
Worked Example
Male, 5’10” (70 inches / 178 cm):
IBW = 50 + 2.3 × (70 − 60)
IBW = 50 + 2.3 × 10
IBW = 50 + 23 = 73 kg
Adjusted Body Weight (ABW):
ABW = IBW + 0.4 × (Actual Wt − IBW)
If actual weight = 110 kg:
ABW = 73 + 0.4 × 37 = 87.8 kg
Key distinction: IBW estimates the weight for which a drug or ventilator parameter was originally calibrated. It is not a goal weight, a health indicator, or a measure of body composition. Clinicians should use IBW for dosing and ventilation — not for nutritional counselling or weight management.
Interpreting %IBW and Dosing Weight
When actual body weight is available, the ratio of actual weight to IBW (%IBW) determines which dosing weight is most appropriate. The table below outlines the general framework used by most pharmacological and ventilation guidelines — though specific drug recommendations may vary.
| %IBW Range | Body Habitus | Recommended Dosing Weight | Rationale |
|---|---|---|---|
| < 80% | Underweight | Actual body weight | Lean mass is reduced; IBW may overestimate drug distribution volume |
| 80–120% | Normal weight | IBW or actual weight | IBW and actual weight are similar; either is acceptable for most drugs |
| 120–130% | Overweight | IBW or adjusted body weight | Some lipophilic drugs may require adjustment above IBW |
| > 130% | Obese | Adjusted body weight (ABW) | ABW accounts for partial drug distribution into adipose tissue (correction factor 0.4) |
The 0.4 correction factor in the ABW formula is an approximation — it assumes that roughly 40% of excess weight above IBW contributes to the volume of distribution for most hydrophilic drugs. For highly lipophilic drugs (e.g., some benzodiazepines, propofol loading doses), actual body weight may be more appropriate. Always consult drug-specific dosing guidelines.
Clinical Applications of IBW
IBW is used across multiple specialties as a reference weight for clinical calculations. The most critical applications are in ventilator management and pharmacological dosing, where using the wrong weight scalar can lead to patient harm.
Lung-protective ventilation, as established by the landmark ARDSNet trial (2000), recommends tidal volumes of 6–8 mL/kg of predicted (ideal) body weight. This is one of the most evidence-based applications of IBW in clinical medicine.
Lung size correlates with height and sex — not total body mass. An obese patient at 150 kg has approximately the same lung volume as a normal-weight patient of the same height and sex. Using actual weight to set tidal volumes in obese patients leads to dangerously high volumes that cause volutrauma and worsen outcomes.
- ARDS: Target 6 mL/kg IBW (range 4–8 mL/kg based on plateau pressure)
- Non-ARDS ventilation: Target 6–8 mL/kg IBW
- Intraoperative ventilation: Growing evidence supports 6–8 mL/kg IBW even in patients without lung disease
Example: A female patient, 165 cm tall, weighing 120 kg. IBW ≈ 57 kg. Tidal volume at 6 mL/kg IBW = 342 mL. Using actual weight would give 720 mL — more than double the appropriate volume.
Many drugs are dosed per kilogram of body weight, but the appropriate weight scalar varies by drug class and pharmacokinetic properties. The key distinction is whether a drug distributes primarily into lean tissue (use IBW), total body water (use actual weight), or somewhere in between (use ABW).
- Aminoglycosides (gentamicin, tobramycin): Use ABW in obese patients. These hydrophilic drugs distribute partially into excess adipose tissue.
- Vancomycin: Use actual body weight for initial dosing — vancomycin has a volume of distribution that increases proportionally with total body weight.
- Low molecular weight heparin (enoxaparin): Use actual body weight for therapeutic dosing, though dose capping may apply at extremes of weight (> 150 kg).
- Neuromuscular blocking agents (succinylcholine): Use actual weight. Rocuronium and vecuronium: use IBW to avoid prolonged paralysis in obese patients.
- Chemotherapy: Many oncology guidelines now recommend dosing on actual body weight or BSA without capping, though toxicity monitoring is essential.
In critical care and clinical nutrition, IBW is sometimes used to estimate energy and protein requirements, particularly when indirect calorimetry is unavailable. The commonly cited target of 25–30 kcal/kg/day typically refers to actual or adjusted body weight — not IBW — though practices vary by institution.
For obese critically ill patients, the ASPEN/SCCM guidelines suggest using IBW or ABW for caloric calculations to avoid overfeeding. High-protein nutrition (≥ 2 g/kg IBW/day) is recommended in critically ill obese patients to preserve lean mass during the catabolic phase of illness.
The %IBW ratio is also used as a screening tool for malnutrition: a %IBW below 80% may suggest moderate malnutrition, while values below 70% are associated with severe malnutrition and increased surgical risk.
The Cockcroft-Gault equation for creatinine clearance requires a body weight input. In obese patients, using actual weight overestimates renal function because it inflates the lean body mass component of the equation. Many pharmacists recommend using ABW or IBW in the Cockcroft-Gault equation when actual weight exceeds 120% of IBW.
For the CKD-EPI and MDRD equations, body weight is not required (they are normalised to body surface area), so IBW is less relevant. However, when renally dosing drugs using Cockcroft-Gault-derived creatinine clearance, the choice of weight scalar directly affects the estimated clearance and, consequently, the drug dose.
Choosing the Right Weight Scalar
Special Populations
The Devine formula was developed using data from a predominantly white, adult population. Its accuracy and applicability vary across several special populations that clinicians frequently encounter.
Paediatric patients: The Devine formula is intended for adults only (typically ≥ 18 years). Paediatric dosing uses age-based or weight-based formulas, and ventilation tidal volumes are calculated using actual body weight (with different mL/kg targets). Do not apply the Devine IBW formula to children or adolescents.
Common Pitfalls & Limitations
This is the single most dangerous misapplication of body weight in clinical medicine. Ventilator tidal volumes set to actual body weight in obese patients can result in volutrauma, barotrauma, and increased mortality. The ARDSNet protocol is based on predicted (ideal) body weight, and all modern ventilator management guidelines reinforce this point.
In a 100 kg patient with an IBW of 65 kg, the difference is a tidal volume of 600 mL (actual) vs. 390 mL (IBW at 6 mL/kg) — a 54% increase that may cause or worsen ventilator-induced lung injury. Always calculate and document IBW at the time of intubation.
The Devine formula subtracts 60 from the height in inches. For patients exactly 5 ft (60 inches) tall, the height-dependent component becomes zero, yielding a fixed IBW of 50 kg for males and 45.5 kg for females. For patients shorter than 5 ft, the formula produces negative height corrections that underestimate appropriate weight.
In clinical practice, many institutions either cap IBW at the 5 ft baseline value or use clinical judgement for patients below this height threshold. Some pharmacists use alternative equations (e.g., Broca index) for very short patients, though none are perfectly validated.
IBW is a pharmacological and physiological reference value — it is not a health goal or a nutritional target. The Devine formula was not derived from morbidity or mortality outcome data for individuals. It was originally adapted from Metropolitan Life Insurance height–weight tables, which themselves reflected the weights associated with lowest group mortality in a specific era and population.
Clinicians should avoid using IBW in counselling patients about weight goals. BMI categories, waist circumference, and individualised metabolic assessments are more appropriate tools for nutritional guidance and weight management discussions.
No single weight metric is correct for all medications. A common error is to apply IBW universally to all weight-based drug doses. This leads to underdosing of drugs that distribute into total body water (e.g., vancomycin) and potentially overdosing drugs that should be dosed on lean mass in underweight patients.
The appropriate weight scalar depends on the drug’s volume of distribution, lipophilicity, and protein binding characteristics. Always consult the specific drug’s dosing guidelines — not a blanket IBW rule. When in doubt, check with the clinical pharmacist and monitor drug levels whenever possible.
The Devine formula uses different baseline constants for males (50 kg) and females (45.5 kg), reflecting average differences in lean body mass at a given height. Applying the male formula to a female patient (or vice versa) results in a 4.5 kg error at every height — which translates to approximately a 27 mL error in tidal volume at 6 mL/kg IBW.
In transgender patients, the choice of formula constant is debated. Many institutions recommend using the sex assigned at birth unless the patient has been on gender-affirming hormone therapy for an extended period, in which case body composition may have shifted. Clinical judgement is essential, and this is an area of evolving guidance.
Quick Reference Summary
Tidal volume target
factor for obesity
Male / Female at 5 ft
above 60 inches
| Clinical Scenario | Weight to Use | Key Example |
|---|---|---|
| Ventilator tidal volume | IBW (always) | 6–8 mL/kg IBW for all ventilated patients |
| Aminoglycosides in obesity | ABW | IBW + 0.4 × (actual − IBW) |
| Vancomycin | Actual body weight | 15–20 mg/kg actual weight per dose |
| Enoxaparin (therapeutic) | Actual body weight | 1 mg/kg actual weight q12h |
| Underweight patient (< 80% IBW) | Actual body weight | Lean mass is reduced; IBW overestimates |
Always use IBW for tidal volume calculation. For drug dosing, the correct weight scalar depends on the specific drug — IBW is not universal. When actual weight exceeds 120% of IBW, consider adjusted body weight for hydrophilic drugs and consult drug-specific guidelines for the appropriate scalar.
Disclaimer & References
For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.
References
- Devine BJ. Gentamicin therapy. Drug Intell Clin Pharm. 1974;8:650–655. DOI: 10.1177/106002807400801104
- The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–1308. DOI: 10.1056/NEJM200005043421801
- Pai MP, Paloucek FP. The origin of the “ideal” body weight equations. Ann Pharmacother. 2000;34(9):1066–1069. DOI: 10.1345/aph.19381
- Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44(10):1051–1065. DOI: 10.2165/00003088-200544100-00004
- Erstad BL. Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med. 2004;30(1):18–32. DOI: 10.1007/s00134-003-2059-6
- Bauer LA, Edwards WAD, Dellinger EP, Simonowitz DA. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol. 1983;24(5):643–647. DOI: 10.1007/BF00542214
- Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci. 1999;88(1):1–7. DOI: 10.1021/js980173a
- McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211. DOI: 10.1177/0148607115621863